NewTimeSpace News: On 28 August 2026, LUMINA GROUP (01162.HK) announced that the major transaction for the formation of a joint venture with Fujian Yuanwang Culture Technology for the "Ode to Gallantry" animated series project had been terminated after the Shenzhen Court of International Arbitration ruled in favour of CoolStudio; the award requires Yuanwang to pay RMB 792,500 in compensation and transfers trailer ownership to CoolStudio, with the Company stating there is no material adverse impact.
NewTimeSpace News: On 28 August 2026, JOINN (06127.HK) announced that the Company and two of its subsidiaries had respectively entered into three-year lease agreements with the Joinn Biologics Group commencing 1 September 2026 for properties in Daxing District, Beijing; with the highest applicable percentage ratio below 0.1%, the transactions qualify as de minimis connected transactions under Rule 14A.76(1)(a) and are fully exempt from disclosure requirements.
NewTimeSpace News: On 28 August 2026, QIAN XUN TECH (01640.HK) announced that it had entered into a sale agreement with Mr. Wu Dan to dispose of the entire issued share capital of Qian Xun HK for RMB 200,000; the disposal group has not actively operated since 2025 and the Company expects a slight loss of approximately RMB 400,000, with the disposal constituting a major transaction under Chapter 14 of the Listing Rules requiring shareholders' approval.
NewTimeSpace News: On 28 August 2026, SINOTRANS (00598.HK) announced that it had entered into a concert party agreement with Sinotrans Container Lines to act in concert on decisions of Antong Holdings; the Company and Sinotrans Container Lines hold approximately 3.98% and 14.94% of Antong Holdings respectively, and the arrangement constitutes a connected transaction with a percentage ratio above 0.1% but below 5%, exempt from independent shareholders' approval.
This week's going-global focus centers on two threads: dense overseas clinical approvals for innovative drugs — two new drugs from CSPC PHARMA won US FDA recognition, and bispecific-antibody pipelines from BAO PHARMA and ANTENGENE received US and Australian regulatory approvals respectively — and accelerated Hong Kong financing, with SHEIN and Mech-Mind launching global offerings, LONGSYS passing its listing hearing, and LEADERDRIVE and Nazhen Technology advancing H-share listings. On the resources side, Mongolia's iron ore project has entered the construction phase and GUSHENGTANG is acquiring 100% of three Malaysian TCM institutions, as Chinese companies' global expansion evolves toward multidimensional coordination of technology, capital and channels.
NewTimeSpace News: On 28 August 2026, BAIYUNSHAN PH (00874.HK) announced that subsidiary Guangzhou Pharmaceutical had signed a delivery confirmation letter with Xingzheng Asset Management to sell accounts receivable with a book value of RMB 149 million, receiving a purchase price of RMB 146,322,872.24; aggregated with past transactions within 12 months, the percentage ratio exceeds 5% but is below 25%, constituting a discloseable transaction not requiring shareholder approval.
NewTimeSpace News: On 28 August 2026, the three major Hong Kong indices ended mixed, with the Hang Seng Index edging up 0.07% to 25,584.79 points, the Hang Seng TECH Index down 0.33%, and turnover at HKD 231.2 billion. Software stocks advanced, with KINGDEE INT'L up 6.23%; gold stocks led gains, with CHINAGOLDINTL up 7.72%; mainland property developers traded actively, with SUNAC up 10.66%. Storage and semiconductor technology names led declines, with VGT down 12.96%; large-model concepts were weak, with Z.AI down over 6% and MINIMAX down over 4%. Southbound capital recorded net buying of HKD 1.176 billion. TIANQI LITHIUM's interim net profit surged 4,925%, GUSHENGTANG's interim profit rose 45.5%, and DIAGENS-B has met the criteria for Stock Connect inclusion.
On August 28, 2026, Hong Kong's three major indices closed mixed, with AI concept stocks diverging on the day and most large-model and AI chip sectors weakening. The Hang Seng Index rose 0.07%, the Hang Seng TECH Index fell 0.33%, and the Hang Seng China Enterprises Index closed flat.In the embodied-AI segment, UBTECH ROBOTICS (09880.HK) closed up 0.66%, XIAOMI-W (01810.HK) rose 1.24%.
NewTimeSpace News: On 28 August 2026, BUSYMING (01768.HK) issued an inside information announcement stating that it had applied to the CSRC to convert 1,536,088 domestic unlisted shares (par value RMB 1.00 each) held by director Mr. Wang Yutong, representing approximately 0.71% of the total issued share capital, into H shares for listing and trading on the Main Board, in a plan to implement the full circulation of H shares; the CSRC filing procedures have not yet been completed.
NewTimeSpace News: On 28 August 2026, CSPC PHARMA (01093.HK) announced that the Phase II clinical trial (SYH2069-004) of SYH2069 Injection for weight management in overweight or obese adult patients had been officially launched at the first study site in China; the product is a GLP-1R/GIPR dual-target dual-biased agonist that obtained the NMPA Drug Clinical Trial Approval Notice in December 2025.
NewTimeSpace News: On 28 August 2026, SBP GROUP (01177.HK) announced that LM-364 "Nectin-4ᵀᴹᴱ ADC", a national Class 1 innovative drug independently developed by wholly-owned subsidiary LaNova Medicines, had obtained implied clinical trial approval from China's NMPA for advanced solid tumors, after receiving FDA approval and initiating clinical trials in Australia in April this year; preclinical data disclosed at the 2026 AACR Annual Meeting showed TGI of up to 168.79% across PDX models.
NewTimeSpace News: On 28 August 2026, HK.AI CAPITAL (01140.HK) announced the appointment of Mr. Tsang Sze Wai as an executive director with effect from 28 August 2026, entitled to a director's fee of HKD 720,000 per annum; Mr. Tsang, aged 49, is a CFA charterholder and former Templeton Asset Management executive who has served as chief executive officer and chairman of multiple Nasdaq-listed SPACs.
NewTimeSpace News: On 28 August 2026, WEI YUAN HLDG (01343.HK) announced that WGC, its indirect wholly-owned subsidiary, has accepted the JTC consent letter to proceed with the redevelopment of the property in Singapore, raising the aggregate plot ratio from 0.85 and 0.90 to 1.40 on a combined basis, with completion required within two years from the date of the consent letter; the redevelopment may constitute a discloseable transaction under Chapter 14 of the Listing Rules.
NewTimeSpace News: On 28 August 2026, FRIENDTIMES (06820.HK) announced that Warm Sunshine, held by controlling shareholder Mr. Jiang Xiaohuang, purchased 1,600,000 shares on the open market on 26 August 2026, representing approximately 0.07% of the total issued share capital; following the purchase, Mr. Jiang's interest increased to 1,254,108,157 shares, representing approximately 57.51% of the total issued share capital.
NewTimeSpace News: On 28 August 2026, SIWI SCI & TECH (01202.HK) announced the lapse and termination of the possible very substantial disposal of its entire interest in Putian New Materials via public listing, as no bids were received during the initial and extended listing periods, with no material adverse impact expected.
NewTimeSpace News: On 31 August 2026, CHK OIL (00632.HK) announced that Mr. Jin Ailong has been re-designated from CEO to CEO (China Business), Mr. Lam Pui Wang has been appointed CEO (Global Business) and Mr. Huang Songjian has been appointed Chief Risk Officer, all effective from 31 August 2026 while continuing as executive directors; Mr. Jin receives HKD 1,320,000 per annum, while Mr. Lam and Mr. Huang each receive HKD 50,000 per month.
